secwatch.observer — SEC 8-K summary
======================================

Issuer:     Invivyd, Inc. (IVVD)
CIK:        0001832038
Form:       8-K
Filed at:   2025-04-21T23:59:59+00:00
Accession:  0000950170-25-056005
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Invivyd secures $30M non-dilutive term loan facility with Silicon Valley Bank
-----------------------------------------------------------------------------

- Up to $30M term loan facility split into three $10M tranches available upon meeting financial covenants and net product revenue milestones.
- Interest rate at WSJ prime minus 0.25% (floor 6%, cap 9%), maturity March 1, 2029; prepayment premiums 3%-0% sliding over three years.
- Loan secured by substantially all assets excluding IP; financial covenants include minimum net product revenue and minimum cash/EBITDA thresholds.
- Proceeds for working capital; company highlights non-dilutive nature and potential FDA alignment on VYD2311 as catalyst.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832038/000095017025056005/0000950170-25-056005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832038/000095017025056005/ivvd-20250418.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-056005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer